Free Trial

Beauty Health (NASDAQ:SKIN) Stock Rating Upgraded by Wall Street Zen

Beauty Health logo with Medical background

Key Points

  • Beauty Health (NASDAQ:SKIN) has been upgraded to a "buy" rating by Wall Street Zen, signaling increased confidence from analysts.
  • The company reported strong quarterly earnings, achieving $0.03 earnings per share, surpassing expectations and generating revenue of $78.20 million.
  • Institutional investors hold a significant stake in Beauty Health, owning approximately 93.26% of the company's shares, indicating robust institutional interest.
  • MarketBeat previews top five stocks to own in October.

Beauty Health (NASDAQ:SKIN - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday.

Several other equities research analysts have also commented on SKIN. Stifel Nicolaus boosted their price target on Beauty Health from $3.00 to $4.00 and gave the stock a "hold" rating in a research note on Friday, August 1st. Canaccord Genuity Group decreased their price target on Beauty Health from $1.50 to $1.25 and set a "hold" rating on the stock in a research note on Monday, May 5th.

View Our Latest Report on Beauty Health

Beauty Health Stock Performance

Shares of SKIN traded up $0.03 during midday trading on Friday, reaching $2.35. 529,481 shares of the stock were exchanged, compared to its average volume of 846,046. The business's 50-day moving average price is $1.80 and its 200 day moving average price is $1.52. The company has a debt-to-equity ratio of 4.91, a current ratio of 5.15 and a quick ratio of 6.43. Beauty Health has a twelve month low of $0.78 and a twelve month high of $2.56. The company has a market capitalization of $295.57 million, a price-to-earnings ratio of -8.41 and a beta of 1.20.

Beauty Health (NASDAQ:SKIN - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.09. The business had revenue of $78.20 million for the quarter, compared to analysts' expectations of $74.67 million. Beauty Health had a negative return on equity of 32.82% and a negative net margin of 6.13%. On average, sell-side analysts expect that Beauty Health will post -0.25 EPS for the current fiscal year.

Institutional Investors Weigh In On Beauty Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Raymond James Financial Inc. acquired a new position in Beauty Health in the 4th quarter valued at $25,000. ProShare Advisors LLC grew its stake in shares of Beauty Health by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 20,959 shares of the company's stock valued at $33,000 after acquiring an additional 6,896 shares in the last quarter. Simplicity Wealth LLC acquired a new stake in shares of Beauty Health during the second quarter valued at about $49,000. AQR Capital Management LLC acquired a new stake in shares of Beauty Health during the first quarter valued at about $40,000. Finally, Police & Firemen s Retirement System of New Jersey grew its stake in shares of Beauty Health by 87.5% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 31,408 shares of the company's stock valued at $60,000 after acquiring an additional 14,653 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company's stock.

About Beauty Health

(Get Free Report)

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

See Also

Should You Invest $1,000 in Beauty Health Right Now?

Before you consider Beauty Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Beauty Health wasn't on the list.

While Beauty Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Rate Cuts: 3 Stocks Set to Benefit Most
Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines